Regulation
Bracco’s VueJect contrast system secures FDA and Health Canada approvals
Bracco Imaging received FDA 510(k) clearance and Health Canada authorization for its VueJect contrast delivery system. The device enables automated injection of contrast media during medical imaging procedures. The approvals expand Bracco's contrast-delivery portfolio in North American markets.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network